Senior insider sale
Chief Development Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$4.63M
80K shares
What this filing means
GUYER WILLIAM plans to sell 80K shares of CORCEPT THERAPEUTICS INC valued at approximately $4.63M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001973251-26-000004
Officer· Chief Development Officer
Since Aug 2021
80K
Shares to sell
$4.63M
Approx. market value
20K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
2/3/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | Stock Option Exercise Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$703.7K
1/6/2026
—Completed
Units to sell
20K
Market value
$1.60M
12/2/2025
—Completed
Units to sell
20K
Market value
$1.51M
11/5/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$814.2K
2/3/2026
Total
Units
80K
Value
$4.63M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 20K | $703.7K | — | Completed |
12/2/2025 | 20K | $1.60M | — | Completed |
11/5/2025 | 20K | $1.51M | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 20K | $814.2K | NASDAQ | Planned |
| Total | 80K | $4.63M | ||